USANA HEALTH SCIENCES, INC. Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid
USANA HEALTH SCIENCES, INC. (USNA) reported Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid of $11.85 million for the 12-month period ending 2019-12-28, per its 10-K filed 2020-02-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForLossesAndLossAdjustmentExpense · last filed 2020-02-25
- USANA HEALTH SCIENCES, INC. liability for unpaid claims and claims adjustment expense, claims paid for fiscal 2019 was $11.85M, a 8.99% increase from fiscal 2018.
- USANA HEALTH SCIENCES, INC. liability for unpaid claims and claims adjustment expense, claims paid for fiscal 2018 was $10.87M, a 18.21% increase from fiscal 2017.
- USANA HEALTH SCIENCES, INC. liability for unpaid claims and claims adjustment expense, claims paid for fiscal 2017 was $9.20M, a 2.00% increase from fiscal 2016.
- USANA HEALTH SCIENCES, INC. liability for unpaid claims and claims adjustment expense, claims paid for fiscal 2016 was $9.02M, a 23.71% increase from fiscal 2016.
| Period end | Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid 12 month |
|---|---|
| 2019-12-28 | $11.85M 10-K · filed 2020-02-25 |
| 2018-12-29 | $10.87M 10-K · filed 2020-02-25 |
| 2017-12-30 | $9.20M 10-K · filed 2020-02-25 |
| 2016-12-31 | $9.02M 10-K · filed 2019-02-26 |
| 2016-01-02 | $7.29M 10-K · filed 2018-02-28 |
| 2015-01-03 | $7.02M 10-K · filed 2017-03-01 |
| 2013-12-28 | $5.28M 10-K · filed 2016-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |